Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Celeste Fonderico
Observed names:
C Fonderico,
C, Fonderico,
C. Fonderico
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Federico II University Hospital,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Naples Federico II
ORCID:
0009-0006-5648-4552
Observed ORCID:
0009-0006-5648-4552
OpenAlex ID:
A5067051931
Obesity: The Perfect Storm for Heart Failure
2024
·
Maria Lembo
, Teresa Strisciuglio
, et al.
·
ESC Heart Failure
·
55
In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy
2025
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
Cancers
·
35
Healthcare Management in Cardio-Oncology, Clinical Strategies and Future Perspectives: A Narrative Review
2025
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
Healthcare
·
12
PDF
PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition
2025
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
International Journal of Molecular Sciences
·
12
PDF
Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients
2023
·
Celeste Fonderico
, Valerio Pergola
, et al.
·
International Journal of Cardiology
·
12
PDF
Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity
2025
·
Vincenzo Quagliariello
, Annabella Di Mauro
, et al.
·
Antioxidants
·
11
Cardioneuroablation: the known and the unknown
2024
·
A. Marrese
, R. Persico
, et al.
·
Frontiers in Cardiovascular Medicine
·
11
Protective Role of Lipid-Lowering Drugs in Breast Cancer: Effects on Cancer Incidence and Cardiotoxicity
2025
·
Alfredo Mauriello
, Adriana Correra
, et al.
·
Life
·
7
PDF
Factor XI and Cancer: Physiopathological Linkage and Clinical Perspectives
2025
·
Alfredo Mauriello
, Anna Chiara Maratea
, et al.
·
Journal of Clinical Medicine
·
7
PDF
Revised protocol for loop recorder implant, maximizing R-wave amplitude minimizes false-positive alarms
2024
·
Luigi Cocchiara
, Benedetta Brescia
, et al.
·
Heart Rhythm
·
6
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology Patients
2025
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
Journal of Cardiovascular Pharmacology
·
4
The Crucial Role of Tinzaparin in Managing Venous Thromboembolism in the Cancer Population
2025
·
Alfredo Mauriello
, Adriana Correra
, et al.
·
Journal of Clinical Medicine
·
4
PDF
The Incremental Role of Stress Echocardiography in Valvular Heart Disease: A Narrative Review
2026
·
Adriana Correra
, Alfredo Mauriello
, et al.
·
Diagnostics
·
3
PDF
Takotsubo Syndrome and Cancer: Pathophysiological Links and Clinical Perspectives
2025
·
Adriana Correra
, Alfredo Mauriello
, et al.
·
Biomedicines
·
2
PDF
Impact of taurolidine use during cardiac electronic implantable device implantation in heart failure patients
2024
·
A Salucci
, V Pergola
, et al.
·
EP Europace
·
2
PDF
Evidence of Cardiotoxic Immune Activation by Triple Immune Checkpoint Blockade: A Translational Alert for Clinical Surveillance in Patients With Cancer
2026
·
Vincenzo Quagliariello
, Margherita Passariello
, et al.
·
Journal of Cardiovascular Pharmacology
·
1
NLRP3/IL-1 and MyD-88/CCL2 pathway were reduced by inclisiran under exposure to anthracyclines and HER-2 blocking agent
2025
·
V Quagliariello
, M Iovine
, et al.
·
European Heart Journal
·
1
A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy
2024
·
D Faccenda
, V Pergola
, et al.
·
EP Europace
·
1
Response to cardiac resynchronization therapy and treatment with ARNi and iSGLT2
2023
·
C Fonderico
, D Faccenda
, et al.
·
EP Europace
·
1
PDF
Intramyocardial Melanoma Metastasis Detecting By18–fdg–pet–ct: a Rare Case Report
2026
·
A Mauriello
, C Fonderico
, et al.
·
European Heart Journal Supplements
26-a-8403-acc Targeting Glp-1 Receptors to Prevent Anthracycline and Her-2 Blocking Agent-related Cardiac Dysfunction: Evidence for Semaglutide Cardioprotection
2026
·
Nicola Maurea
, Annabella Di Mauro
, et al.
·
Journal of the American College of Cardiology
PDF
26-a-8322-acc Pcsk9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure Via Nlrp3 and Myd88 Pathway Inhibition
2026
·
Nicola Maurea
, Massimiliano Berretta
, et al.
·
Journal of the American College of Cardiology
26-a-8402-acc Metabolic Modulation by Sglt2 Inhibitors Canagliflozin and Dapagliflozin: a Novel Strategy to Balance Antitumor Efficacy and Cardiotoxicity in Her2-positive Breast Cancer Therapy
2026
·
Nicola Maurea
, Massimiliano Berretta
, et al.
·
Journal of the American College of Cardiology
26-a-8399-acc Nlrp3 Selective Antagonist Reduces Anthracycline+/-trastuzumab Induced Cardiotoxicity Through Inhibition of Ferroptosis and Activation of Pampk Pathways in Hipsc-cms Cells
2026
·
Nicola Maurea
, Massimiliano Berretta
, et al.
·
Journal of the American College of Cardiology
26-A-8699-ACC SGLT2 INHIBITOR DAPAGLIFLOZIN ATTENUATES CARDIOMYOCYTE INJURY INDUCED BY PI3Kα-SELECTIVE INHIBITOR ALPELISIB AND FULVESTRANT UNDER HYPERGLYCEMIA
2026
·
Nicola Maurea
, Massimiliano Berretta
, et al.
·
Journal of the American College of Cardiology
Show more works
View as search
Works count:
30
Citation count:
187
H-index:
7
I10-index:
7
Year
Topic
Type